當前位置:BPS Bioscience Inc.>>Immunotherapy Cell Lines>> 60535PD-1 / NFAT Reporter - Jurkat Recombinant Cell Line
Recombinant Jurkat T cells constitutively expressing human PD-1 (Programmed Cell Death 1, also known as PDCD1, SLEB2, CD279, GenBank Accession #NM_005018), and with conditional expression of the firefly luciferase gene under the control of NFAT response elements located upstream of the minimal TATA promoter. Stimulation of NFAT can therefore be monitored by measuring luciferase activity.
Illustration of a suggested co-culture experiment. The TCR activator present at the surface of TCRa/PD-L1 CHO cells stimulates TCR in Jurkat T cells, whereas overexpression of PD-L1 on the CHO cell line engages Jurkat PD-1, which blocks TCR activation signals and prevents activation of NFAT. Addition of a neutralizing anti-PD-1 or anti-PD-L1 antibody to the co-culture releases the PD-L1/PD-1 brake and results in TCR activation and increased NFAT activity, which translates into increased luciferase reporter signal.
This product has been cited 21 times.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,化工儀器網對此不承擔任何保證責任。
溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。